An interpretable AI system reduces false-positive MRI diagnoses by stratifying high-risk breast lesions.
This study reports development and validation of BL4AS, an AI system to improve MRI-based diagnosis of BI-RADS 4 breast...
Beyond the hype: Antibody-Drug Conjugates are advancing faster than our clinical strategy.
- Post category:Breast Cancer
- Reading time:2 mins read
This article is a concise, practice-oriented review of the current and emerging role of antibody-drug conjugates (ADCs)...
Axillary Surgery in Breast Cancer: Evidence-Based De-escalation Across Upfront and Post-Neoadjuvant Settings Running title: Modern Trends in Axillary Surgery.
- Post category:Breast Cancer
- Reading time:2 mins read
This publication is a narrative review of the progressive de-escalation of axillary surgery in breast cancer and synthes...
Dynamic biomarkers in hormone receptor-positive/HER2-negative breast cancer trials: a new hope for precision oncology.
- Post category:Breast Cancer
- Reading time:1 min read
This publication reviews how hormone receptor–positive, HER2‑negative breast cancer changes under the selective pres...
Racial and ethnic disparities in neoadjuvant chemotherapy patterns and outcomes in early-stage HER2-positive breast cancer.
- Post category:Breast Cancer
- Reading time:2 mins read
This population-based study evaluated trends and outcomes of neoadjuvant chemotherapy (NACT) in adults with stage I–II...
Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion.
- Post category:Breast Cancer
- Reading time:2 mins read
The publication is a practical, toxicity-management focused review of capivasertib plus fulvestrant in HR-positive, HER2...